Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
carbapenemase
Overview
In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
The study characterizes the lytic bacteriophage Bϕ-C62, which targets OXA-66-like carbapenemase-producing Acinetobacter baumannii strains, showing therapeutic potential against multidrug-resistant clinical isolates.
No comments yet. Be the first to comment!